A Study of Esketamine Nasal Spray in Korean Participants With Treatment-resistant Depression

Recruiting

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(6 sites)

South Korea

Cha Ilsan Medical Center, Goyang Si Gyeonggi Do

Wonkwang University Hospital, Iksan

Kangbuk Samsung Hospital, Seoul

Asan Medical Center, Seoul

Samsung Medical Center, Seoul

Kyung Hee University Hospital, Seoul